Skip to main content

Table 1 Patient’s histories and clinical features at presentation

From: Finding the right BCR-ABL1 tyrosine kinase inhibitor: a case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilotinib

Patient histories
 Medical history Chronic obstructive pulmonary disease and surgically treated prostate cancer
 Surgical history Prostatectomy, cholecystectomy, and hernia repair
 Social history 88 pack-years of smoking and consumption of 2 alcoholic beverages per day; no history of illicit drug use
 Family history No family history of blood disorders, clotting disorders, or malignancies
Clinical features at presentation
 White blood cell count, cells/μL 147,000
 Basophils, % 10
 Absolute neutrophil count, cells/μL 116,210
 Platelet count, platelets/μL 230,000
 Hemoglobin, g/dL 13.1
 Abdominal ultrasound Splenomegaly of ≈ 16 cm
 Lactate dehydrogenase, U/L 1005